Kronos Bio, Inc.

NASDAQ:KRON

0.9 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -112.673-133.204-151.078-88.444-16.117-6.721
Depreciation & Amortization 4.9162.2661.9770.8390.3560.091
Deferred Income Tax 4.14803.9970.326-0.0040
Stock Based Compensation 24.98231.14526.2113.7530.1130.03
Change In Working Capital 5.8766.178-1.626.460.2760.09
Accounts Receivables 000000
Inventory 000000
Accounts Payables -4.1484.025-3.1952.8070.716-0.028
Other Working Capital 10.0242.1531.5753.653-0.440.118
Other Non Cash Items -5.8312.6892.58939.1540.2940.069
Operating Cash Flow -78.582-90.926-117.924-37.912-15.082-6.441
Investing Activities:
Investments In Property Plant And Equipment -0.679-0.577-4.26-9.568-2.948-1.075
Acquisitions Net 031.645-67.984150.66700
Purchases Of Investments -212.957-367.124-177.734-229.328-64.6330
Sales Maturities Of Investments 280.004335.479245.71878.66100
Other Investing Activites -0-31.64567.984-150.667-64.6330
Investing Cash Flow 66.368-32.22263.724-160.235-67.581-1.075
Financing Activities:
Debt Repayment 00-0.005-0.032-0.03-0.072
Common Stock Issued 0.5670.8514.465263.7250.1150.005
Common Stock Repurchased 0.5380.381.338000
Dividends Paid 000000
Other Financing Activities 0.5670.8514.465151.92104.92216.285
Financing Cash Flow 0.5670.8514.46415.613105.00716.218
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -11.647-122.297-49.74217.46622.3448.702
Cash At End Of Period 64.32677.999200.296250.03632.5710.226